These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiac Toxicity in a Patient Receiving Peptide Receptor Radionuclide Therapy. Hendifar AE; Delpassand ES; Kittleson MM; Tuli R Pancreas; 2018 Sep; 47(8):e55-e56. PubMed ID: 30113434 [No Abstract] [Full Text] [Related]
3. Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues. Bodei L; Pepe G; Paganelli G Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):347-51. PubMed ID: 20496546 [TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors. Kwekkeboom DJ; de Herder WW; Krenning EP Endocrinol Metab Clin North Am; 2011 Mar; 40(1):173-85, ix. PubMed ID: 21349418 [TBL] [Abstract][Full Text] [Related]
5. Treatment with Estorch M Rev Esp Med Nucl Imagen Mol; 2017; 36(2):69-71. PubMed ID: 28257748 [No Abstract] [Full Text] [Related]
6. Polish experience in Peptide receptor radionuclide therapy. Kunikowska J; Królicki L; Sowa-Staszczak A; Hubalewska-Dydejczyk A; Pawlak D; Mikolajczak R; Handkiewicz-Junak D; Szaluś N; Kamiński G; Cwikla J; Jakuciński M; Lukiewicz A; Kowalska A; Gut P Recent Results Cancer Res; 2013; 194():467-78. PubMed ID: 22918776 [TBL] [Abstract][Full Text] [Related]
7. Radionuclide Therapy for Neuroendocrine Tumors. Cives M; Strosberg J Curr Oncol Rep; 2017 Feb; 19(2):9. PubMed ID: 28220446 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings. De Jong M; Valkema R; Jamar F; Kvols LK; Kwekkeboom DJ; Breeman WA; Bakker WH; Smith C; Pauwels S; Krenning EP Semin Nucl Med; 2002 Apr; 32(2):133-40. PubMed ID: 11965608 [TBL] [Abstract][Full Text] [Related]
9. PRRT as neoadjuvant treatment in NET. Sowa-Staszczak A; Hubalewska-Dydejczyk A; Tomaszuk M Recent Results Cancer Res; 2013; 194():479-85. PubMed ID: 22918777 [TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Breeman WA; de Jong M; Kwekkeboom DJ; Valkema R; Bakker WH; Kooij PP; Visser TJ; Krenning EP Eur J Nucl Med; 2001 Sep; 28(9):1421-9. PubMed ID: 11585303 [TBL] [Abstract][Full Text] [Related]
11. Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms. Kaemmerer D; Twrznik M; Kulkarni HR; Hörsch D; Sehner S; Baum RP; Hommann M; Ann Surg; 2021 Jul; 274(1):e45-e53. PubMed ID: 33030849 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up. Hörsch D; Ezziddin S; Haug A; Gratz KF; Dunkelmann S; Miederer M; Schreckenberger M; Krause BJ; Bengel FM; Bartenstein P; Biersack HJ; Pöpperl G; Baum RP Eur J Cancer; 2016 May; 58():41-51. PubMed ID: 26943056 [TBL] [Abstract][Full Text] [Related]
13. New advances in peptide receptor radionuclide therapy. de Jong M; Krenning E J Nucl Med; 2002 May; 43(5):617-20. PubMed ID: 11994523 [No Abstract] [Full Text] [Related]
14. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807 [TBL] [Abstract][Full Text] [Related]
15. Hervás I; Bello P; Falgas M; Del Olmo MI; Torres I; Olivas C; Vera V; Oliván P; Yepes AM Rev Esp Med Nucl Imagen Mol; 2017; 36(2):91-98. PubMed ID: 27889527 [TBL] [Abstract][Full Text] [Related]
16. Repeated cycles of peptide receptor radionuclide therapy (PRRT)--results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET. Pach D; Sowa-Staszczak A; Kunikowska J; Królicki L; Trofimiuk M; Stefańska A; Tomaszuk M; Głowa B; Mikołajczak R; Pawlak D; Jabrocka-Hybel A; Hubalewska-Dydejczyk AB Radiother Oncol; 2012 Jan; 102(1):45-50. PubMed ID: 21885142 [TBL] [Abstract][Full Text] [Related]